Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
58.92
+0.14 (0.24%)
Nov 13, 2024, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $5.46 billion as of November 13, 2024. Its market cap has increased by 244.54% in one year.
Market Cap
5.46B
Enterprise Value
4.65B
1-Year Change
244.54%
Ranking
Category
Stock Price
$58.92
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $539.40M to $5.46B, an increase of 913.00%. That is a compound annual growth rate of 44.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 4.70B | 97.94% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.70M | -27.03% |
| Dec 31, 2021 | 1.35B | 190.53% |
| Dec 31, 2020 | 464.50M | -23.56% |
| Dec 31, 2019 | 607.70M | -15.70% |
| Dec 31, 2018 | 720.90M | 33.65% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merit Medical Systems | 6.02B |
| Lantheus Holdings | 5.78B |
| Stevanato Group | 5.66B |
| Inspire Medical Systems | 5.58B |
| Arcellx | 5.57B |
| Krystal Biotech | 5.39B |
| Waystar Holding | 5.37B |
| ADMA Biologics | 5.23B |